JAK-inhibitors for coronavirus disease-2019 (COVID-19): a meta-analysis

We analyzed reports on safety and efficacy of JAK-inhibitors in patients with coronavirus infectious disease-2019 (COVID-19) published between January 1st and March 6th 2021 using the Newcastle-Ottawa and Jadad scales for quality assessment. We used disease severity as a proxy for time when JAK-inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chong-xiang, Wang, Jiao-jiao, Li, Huan, Yuan, Le-tao, Gale, Robert Peter, Liang, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119232/
https://www.ncbi.nlm.nih.gov/pubmed/33990684
http://dx.doi.org/10.1038/s41375-021-01266-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119232/
https://www.ncbi.nlm.nih.gov/pubmed/33990684
http://dx.doi.org/10.1038/s41375-021-01266-6

Ejemplares similares